163 related articles for article (PubMed ID: 30059366)
1. Dysregulation of bcl-2 enhanced rotenone-induced α-synuclein aggregation associated with autophagic pathways.
Chen Y; Zhang N; Ji D; Hou Y; Chen C; Fu Y; Ge R; Zheng Q; Chen J; Wang H
Neuroreport; 2018 Sep; 29(14):1201-1208. PubMed ID: 30059366
[TBL] [Abstract][Full Text] [Related]
2. Monoamine Oxidase-B Inhibition Facilitates α-Synuclein Secretion
Nakamura Y; Arawaka S; Sato H; Sasaki A; Shigekiyo T; Takahata K; Tsunekawa H; Kato T
J Neurosci; 2021 Sep; 41(35):7479-7491. PubMed ID: 34290084
[TBL] [Abstract][Full Text] [Related]
3. Neural-Induced Human Adipose Tissue-Derived Stem Cells Conditioned Medium Ameliorates Rotenone-Induced Toxicity in SH-SY5Y Cells.
Ramalingam M; Jang S; Jeong HS
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652595
[TBL] [Abstract][Full Text] [Related]
4. Fasudil Promotes α-Synuclein Clearance in an AAV-Mediated α-Synuclein Rat Model of Parkinson's Disease by Autophagy Activation.
Yang YJ; Bu LL; Shen C; Ge JJ; He SJ; Yu HL; Tang YL; Jue Z; Sun YM; Yu WB; Zuo CT; Wu JJ; Wang J; Liu FT
J Parkinsons Dis; 2020; 10(3):969-979. PubMed ID: 32568105
[TBL] [Abstract][Full Text] [Related]
5. P75 Involved in the Ubiquitination of α-synuclein in Rotenone-based Parkinson's Disease Models.
Chen Y; Hou Y; Yang J; Du R; Chen C; Chen F; Wang H; Ge R; Chen J
Neuroscience; 2018 Sep; 388():367-373. PubMed ID: 30081046
[TBL] [Abstract][Full Text] [Related]
6. Rotenone impairs autophagic flux and lysosomal functions in Parkinson's disease.
Wu F; Xu HD; Guan JJ; Hou YS; Gu JH; Zhen XC; Qin ZH
Neuroscience; 2015 Jan; 284():900-911. PubMed ID: 25446361
[TBL] [Abstract][Full Text] [Related]
7. Microglia-specific knock-out of NF-κB/IKK2 increases the accumulation of misfolded α-synuclein through the inhibition of p62/sequestosome-1-dependent autophagy in the rotenone model of Parkinson's disease.
Rocha SM; Kirkley KS; Chatterjee D; Aboellail TA; Smeyne RJ; Tjalkens RB
Glia; 2023 Sep; 71(9):2154-2179. PubMed ID: 37199240
[TBL] [Abstract][Full Text] [Related]
8. Serum Response Factor Promotes Dopaminergic Neuron Survival via Activation of Beclin 1-Dependent Autophagy.
Cheng XY; Li SY; Mao CJ; Wang MX; Chen J; Wang F; Wang GH; Deng WB; Li XK; Liu CF
Neuroscience; 2018 Feb; 371():288-295. PubMed ID: 29196028
[TBL] [Abstract][Full Text] [Related]
9. Oxidants induce alternative splicing of alpha-synuclein: Implications for Parkinson's disease.
Kalivendi SV; Yedlapudi D; Hillard CJ; Kalyanaraman B
Free Radic Biol Med; 2010 Feb; 48(3):377-83. PubMed ID: 19857570
[TBL] [Abstract][Full Text] [Related]
10. Myrcene Salvages Rotenone-Induced Loss of Dopaminergic Neurons by Inhibiting Oxidative Stress, Inflammation, Apoptosis, and Autophagy.
Azimullah S; Jayaraj RL; Meeran MFN; Jalal FY; Adem A; Ojha S; Beiram R
Molecules; 2023 Jan; 28(2):. PubMed ID: 36677744
[TBL] [Abstract][Full Text] [Related]
11. Ellagic Acid Prevents α-Synuclein Aggregation and Protects SH-SY5Y Cells from Aggregated α-Synuclein-Induced Toxicity via Suppression of Apoptosis and Activation of Autophagy.
Ardah MT; Eid N; Kitada T; Haque ME
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948195
[TBL] [Abstract][Full Text] [Related]
12. Immunoproteasome is up-regulated in rotenone-induced Parkinson's disease rat model.
Sun C; Jia G; Wang X; Wang Y; Liu Y
Neurosci Lett; 2020 Nov; 738():135360. PubMed ID: 32905834
[TBL] [Abstract][Full Text] [Related]
13. Hydroxysafflor yellow A promotes α-synuclein clearance via regulating autophagy in rotenone-induced Parkinson's disease mice.
Han B; Wang L; Fu F; Wang Z; Zhang L; Qi GJ; Wang T
Folia Neuropathol; 2018; 56(2):133-140. PubMed ID: 30509033
[TBL] [Abstract][Full Text] [Related]
14. Intranasal Exposure to Low-Dose Rotenone Induced Alpha-Synuclein Accumulation and Parkinson's Like Symptoms Without Loss of Dopaminergic Neurons.
Sharma M; Kaur J; Rakshe S; Sharma N; Khunt D; Khairnar A
Neurotox Res; 2022 Feb; 40(1):215-229. PubMed ID: 34817799
[TBL] [Abstract][Full Text] [Related]
15. Exosome release and neuropathology induced by α-synuclein: new insights into protective mechanisms of Drp1 inhibition.
Fan RZ; Guo M; Luo S; Cui M; Tieu K
Acta Neuropathol Commun; 2019 Nov; 7(1):184. PubMed ID: 31744532
[TBL] [Abstract][Full Text] [Related]
16. Astragaloside IV Inhibits Rotenone-Induced α-syn Presentation and the CD4 T-Cell Immune Response.
Wang M; Sun F; Han X; Wang N; Liu Y; Cai J; Tong S; Wang R; Wang H
Mol Neurobiol; 2024 Jan; 61(1):252-265. PubMed ID: 37603153
[TBL] [Abstract][Full Text] [Related]
17. TNF compromises lysosome acidification and reduces α-synuclein degradation via autophagy in dopaminergic cells.
Wang MX; Cheng XY; Jin M; Cao YL; Yang YP; Wang JD; Li Q; Wang F; Hu LF; Liu CF
Exp Neurol; 2015 Sep; 271():112-21. PubMed ID: 26001614
[TBL] [Abstract][Full Text] [Related]
18. α-synuclein suppresses microglial autophagy and promotes neurodegeneration in a mouse model of Parkinson's disease.
Tu HY; Yuan BS; Hou XO; Zhang XJ; Pei CS; Ma YT; Yang YP; Fan Y; Qin ZH; Liu CF; Hu LF
Aging Cell; 2021 Dec; 20(12):e13522. PubMed ID: 34811872
[TBL] [Abstract][Full Text] [Related]
19. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
Perfeito R; Cunha-Oliveira T; Rego AC
Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
[TBL] [Abstract][Full Text] [Related]
20. Neonatal exposure to lipopolysaccharide enhances accumulation of α-synuclein aggregation and dopamine transporter protein expression in the substantia nigra in responses to rotenone challenge in later life.
Tien LT; Kaizaki A; Pang Y; Cai Z; Bhatt AJ; Fan LW
Toxicology; 2013 Jun; 308():96-103. PubMed ID: 23567316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
